Tango Therapeutics (TNGX) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to 0.76.
- Tango Therapeutics' Equity Ratio rose 1711.17% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year increase of 1711.17%. This contributed to the annual value of 0.63 for FY2024, which is 26.5% up from last year.
- Per Tango Therapeutics' latest filing, its Equity Ratio stood at 0.76 for Q3 2025, which was up 1711.17% from 0.57 recorded in Q2 2025.
- Tango Therapeutics' 5-year Equity Ratio high stood at 0.76 for Q3 2025, and its period low was 0.03 during Q1 2021.
- Moreover, its 5-year median value for Equity Ratio was 0.63 (2024), whereas its average is 0.57.
- In the last 5 years, Tango Therapeutics' Equity Ratio soared by 222126.86% in 2021 and then crashed by 1715.52% in 2023.
- Over the past 5 years, Tango Therapeutics' Equity Ratio (Quarter) stood at 0.69 in 2021, then dropped by 17.08% to 0.57 in 2022, then increased by 10.0% to 0.63 in 2023, then grew by 0.27% to 0.63 in 2024, then rose by 20.81% to 0.76 in 2025.
- Its Equity Ratio was 0.76 in Q3 2025, compared to 0.57 in Q2 2025 and 0.61 in Q1 2025.